Fellows National Video Conference Series Articles July 2018

Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses

Se Hoon Park, Tae Sung Sohn, Jeeyun Lee, Do Hoon Lim, Min Eui Hong, Kyoung-Mee Kim, Insuk Sohn, Sin Ho Jung, Min Gew Choi, Jun Ho Lee, Jae Moon Bae, Sung Kim, Seung Tae Kim, Joon Oh Park, Young Suk Park, Ho Yeong Lim, and Won Ki Kang

Download the PDF


Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial

Annemieke Cats*, Edwin P M Jansen*, Nicole C T van Grieken, Karolina Sikorska, Pehr Lind, Marianne Nordsmark, Elma Meershoek-Klein Kranenbarg, Henk Boot, Anouk K Trip, H A Maurits Swellengrebel, Hanneke W M van Laarhoven, Hein Putter, Johanna W van Sandick,
Mark I van Berge Henegouwen, Henk H Hartgrink, Harm van Tinteren, Cornelis J H van de Velde†, Marcel Verheij†, for the CRITICS investigators

Download the PDF


Efficacy of Adjuvant Chemotherapy for Small Bowel Adenocarcinoma: A Propensity Score–Matched Analysis

Aslam Ejaz MD1 | Brad N. Brett L. Ecker, MD1; Matthew T. McMillan, BA1; Jashodeep Datta, MD1; Ronac Mamtani, MD, MSCE2; Bruce J. Giantonio, MD2; Daniel T. Dempsey, MD1; Douglas L. Fraker, MD1; Jeffrey A. Drebin, MD, PhD1; Giorgos C. Karakousis, MD1; and Robert E. Roses, MD1

Download the PDF


Patterns of Recurrence After Surgery Alone Versus Preoperative Chemoradiotherapy and Surgery in the CROSS Trials

Vera Oppedijk, Ate van der Gaast, Jan J.B. van Lanschot, Pieter van Hagen, Rob van Os, Caroline M. van Rij, Maurice J. van der Sangen, Jannet C. Beukema, Heidi Ru¨tten, Patty H. Spruit, Janny G. Reinders, Dick J. Richel, Mark I. van Berge Henegouwen, and Maarten C.C.M. Hulshof

Download the PDF


North Central Cancer Treatment Group N0543 (Alliance): A Phase 2 Trial of Pharmacogenetic-Based Dosing of Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy for Patients With Advanced Small Bowel Adenocarcinoma

Robert R. McWilliams, MD 1; Nathan R. Foster, MS2; Michelle R. Mahoney, MS2; Thomas C. Smyrk, MD3; Joseph A. Murray, MD4; Matthew M. Ames, PhD5; L. Elise Horvath, MD6; Daniel J. Schneider, MD7; Timothy J. Hobday, MD1; Aminah Jatoi, MD 1; Jeffrey P. Meyers, BA2; and Matthew P. Goetz, MD

Download the PDF


NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma

Somnath Mukherjee a,1, Christopher Nicholas Hurt b,*,1, Sarah Gwynne c, David Sebag-Montefiore d, Ganesh Radhakrishna d, Simon Gollins e, Maria Hawkins a, Heike I. Grabsch f,g, Gareth Jones h, Stephen Falk i, Ricky Sharma a, Andrew Bateman j, Rajarshi Roy k, Ruby Ray b, Jo Canham b, Gareth Griffiths l, Tim Maughan a, Tom Crosby

Download the PDF


Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial

Elizabeth C. Smyth, Matteo Fassan, David Cunningham, William H. Allum, Alicia F.C. Okines, Andrea Lampis, Jens C. Hahne,Massimo Rugge, Clare Peckitt,Matthew Nankivell, Ruth Langley,Michele Ghidini, Chiara Braconi, Andrew Wotherspoon, Heike I. Grabsch, and Nicola Valeri

Download the PDF


Patients with Adenocarcinoma of the Small Intestine with 9 or More Regional Lymph Nodes Retrieved Have a Higher Rate of Positive Lymph Nodes and Improved Survival

Alexander Wilhelm1 & Sascha A. Müller1 & Thomas Steffen1 & Bruno M. Schmied1 &
Ulrich Beutner1 & Rene Warschkow1,2

Download the PDF


Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fl uorouracil, and leucovorin versus epirubicin, cisplatin, and fl uorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial

Salah-Eddin Al-Batran, Ralf D Hofh einz, Claudia Pauligk, Hans-Georg Kopp, Georg Martin Haag, Kim Barbara Luley, Johannes Meiler, Nils Homann, Sylvie Lorenzen, Harald Schmalenberg, Stephan Probst, Michael Koenigsmann, Matthias Egger, Nicole Prasnikar, Karel Caca, Jörg Trojan, Uwe M Martens, Andreas Block, Wolfgang Fischbach, Rolf Mahlberg, Michael Clemens, Gerald Illerhaus, Katja Zirlik, Dirk M Behringer, Wolff Schmiegel, Michael Pohl, Michael Heike, Ulrich Ronellenfi tsch, Martin Schuler, Wolf O Bechstein, Alfred Königsrainer, Timo Gaiser, Peter Schirmacher, Wael Hozaeel, Alexander Reichart, Thorsten O Goetze, Mark Sievert, Elke Jäger, Stefan Mönig, Andrea Tannapfel

Download the PDF